Dr. Shandas has a long history of translating engineering ideas into successful clinical products and techniques. He pioneered the Echo PIV technique, an opaque flow velocimetry technique for measuring details of cardiovascular blood flow through high frame rate ultrasound imaging coupled with contrast backscatter. In pediatric cardiology, he helped develop the idea that the large pulmonary arteries play a key role in maintaining right-ventricular pumping action (the RV-PA dual-ventricle) during pulmonary hypertension. In pediatric cardiac surgery, he co-developed novel methods to assist the failing Fontan. Over the last 10 years, he co-founded 8 companies in a variety of medtech areas including new shape memory polymers for cardiovascular and ophthalmic applications (EndoShape, ShapeTech, Shape Ophthalmics), Echo PIV for hemodynamic vascular profiling (Illumasonix), new surgical bed for hip arthroscopy (MITA), and new techniques to quantify esophageal inflammation (EnteroTrack). Many of these companies have products in the clinic; one (MITA) was recently acquired by Stryker. He is actively involved in mentoring undergraduate and graduate students, medical fellows, and junior faculty. Many of his trainees are now in leadership positions in academia, industry or research. Dr. Shandas founded the first bioengineering department in Colorado and established the BS, MS, and PhD degrees in bioengineering.